Matt Murphy
Manager of Investor Relations
Replay available
Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call
Cara Therapeutics, Inc. (NASDAQ: CARA) Q4 2023 earnings conference call, held 2024-03-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Posner
Chief Executive Officer
Unknown Speaker
Unknown
Ryan Maynard
Chief Financial Officer
Dr. Joanna Consalves
Chief Medical Officer
Annabelle Cimini
Analyst, Stifel
Joseph Stringer
Analyst, Needham & Company
Dennis Ding
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.251 Thank you for standing by, and welcome to Kara Therapeutics' fourth quarter and full 00:00:05.251 -- 00:00:07.472 year 2023 earnings 00:00:07.472 -- 00:00:12.675 conference call. At this time, all participants are in a listen-only mode. 00:00:12.675 -- 00:00:17.117 After the speaker presentation, there will be a question and answer session. 00:00:17.117 -- 00:00:22.459 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:22.459 -- 00:00:27.336 To remove yourself from the question queue, you may press star 1 1 again. 00:00:27.336 -- 00:00:31.979 I would now like to hand the call over to Matt Murphy, Manager of Investor Relations. 00:00:31.979 -- 00:00:34.719 Please go ahead. 00:00:35.240 -- 00:00:40.383 Thank you, Operator, and good afternoon. After market closed today, CARA issued a news 00:00:40.383 -- 00:00:44.805 release announcing the company's financial and operating results for the fourth quarter 00:00:44.805 -- 00:00:47.236 and full year 2023. 00:00:47.667 -- 00:00:53.869 Copies of this news release can be found in the Investor section of our website at caratherapeutics.com. 00:00:54.383 -- 00:00:58.546 Before we begin, let me remind you that during the course of this conference call, we 00:00:58.546 -- 00:01:03.290 will be making certain forward-looking statements about CARA and our program based on 00:01:03.290 -- 00:01:06.272 management's current plans and expectations. 00:01:06.272 -- 00:01:10.525 These statements are being made under the Private Securities Litigation Reform Act of 00:01:10.525 -- 00:01:11.996 1995 00:01:11.996 -- 00:01:15.079 and are subject to risks and uncertainties. 00:01:15.079 -- 00:01:20.223 Actual results may differ materially due to various factors, and ...